249 related articles for article (PubMed ID: 15636329)
1. Clinical utility of screening for antinuclear antibodies by enzyme immunoassay--a preliminary study.
Divate S; Hardikar P; Bichile LS; Rajadhyaksha A
J Assoc Physicians India; 2004 Apr; 52():290-3. PubMed ID: 15636329
[TBL] [Abstract][Full Text] [Related]
2. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
Homburger HA; Cahen YD; Griffiths J; Jacob GL
Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
[TBL] [Abstract][Full Text] [Related]
3. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
4. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
5. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.
Sjöwall C; Sturm M; Dahle C; Bengtsson AA; Jönsen A; Sturfelt G; Skogh T
J Rheumatol; 2008 Oct; 35(10):1994-2000. PubMed ID: 18785312
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of antinuclear antibody detection by indirect immunofluorescence and enzyme immunoassay in lupus patients.
El-Chennawi FA; Mosaad YM; Habib HM; El-Degheidi T
Immunol Invest; 2009; 38(8):839-50. PubMed ID: 19860592
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis.
Copple SS; Sawitzke AD; Wilson AM; Tebo AE; Hill HR
Am J Clin Pathol; 2011 May; 135(5):678-84. PubMed ID: 21502422
[TBL] [Abstract][Full Text] [Related]
8. Antinuclear antibody testing. A study of clinical utility.
Slater CA; Davis RB; Shmerling RH
Arch Intern Med; 1996 Jul; 156(13):1421-5. PubMed ID: 8678710
[TBL] [Abstract][Full Text] [Related]
9. Use of ELISA to measure antinuclear antibodies in children with juvenile rheumatoid arthritis.
Fawcett PT; Rose CD; Gibney KM; Emerich MJ; Athreya BH; Doughty RA
J Rheumatol; 1999 Aug; 26(8):1822-6. PubMed ID: 10451083
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies.
Shovman O; Gilburd B; Barzilai O; Shinar E; Larida B; Zandman-Goddard G; Binder SR; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1050():380-8. PubMed ID: 16014555
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody.
Kim KH; Han JY; Kim JM; Lee SW; Chung WT
Clin Chim Acta; 2007 May; 380(1-2):182-5. PubMed ID: 17355877
[TBL] [Abstract][Full Text] [Related]
12. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.
Yu L; Wang J; O'Dell JR; Oates J; Arend WP; Eisenbarth GS
J Rheumatol; 2007 Apr; 34(4):734-9. PubMed ID: 17407230
[TBL] [Abstract][Full Text] [Related]
13. [THE CLINICAL INFORMATIVENESS OF AUTOMATED METHODS OF SCREENING DETECTION OF ANTI-NUCLEAR ANTIBODIES USING INDIRECT REACTION OF IMMUNE FLUORESCENCE, ENZYME-LINKED IMMUNOSORBENT ASSAY AND MULTIPLEX XMAP TECHNOLOGY UNDER SYSTEMIC LUPUS ERYTHEMATOSUS].
Verizhnikova ZG; Aleksandrova EN; Novikov AA; Panafidina TA; Seredavkina NV; Popkova TV; Aizina NL; Nasonov EL
Klin Lab Diagn; 2017 Mar; 62(3):173-7. PubMed ID: 30620533
[TBL] [Abstract][Full Text] [Related]
14. Double stranded DNA antibody estimation for the diagnosis of systematic lupus erythematosus [corrected].
Mohanalingam U; Mathai E; Sridharan G
Indian J Pathol Microbiol; 1993 Jul; 36(3):265-7. PubMed ID: 8093130
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of antinuclear antibody tests in children.
McGhee JL; Kickingbird LM; Jarvis JN
BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
[TBL] [Abstract][Full Text] [Related]
16. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies].
Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N
Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
Půtová I; Dostal C; Becvar R
Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
[TBL] [Abstract][Full Text] [Related]
19. High sensitive detection of double-stranded DNA autoantibodies by a modified Crithidia luciliae immunofluorescence test.
Conrad K; Ittenson A; Reinhold D; Fischer R; Roggenbuck D; Büttner T; Bosselmann HP; Steinbach J; Schössler W
Ann N Y Acad Sci; 2009 Sep; 1173():180-5. PubMed ID: 19758148
[TBL] [Abstract][Full Text] [Related]
20. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]